Resources from the same session
360O - Telomerase reverse transcriptase (TERT) promoter mutation and O6-methylguanine DNA methyltransferase (MGMT) promoter methylation-mediated sensitivity to temozolomide in IDH-wildtype glioblastoma: Is there a link?
Presenter: Michael Weller
Session: Proffered Paper - CNS tumours
Resources:
Abstract
Slides
Webcast
361O - Defining the prognostic role of MGMT methylation value by pyrosequencing assay in glioblastoma patients: A large Italian multicenter study
Presenter: Mario Caccese
Session: Proffered Paper - CNS tumours
Resources:
Abstract
Slides
Webcast
362O - Perifocal edema volume correlates with density of tumour-infiltrating cytotoxic T cells in newly diagnosed glioblastoma
Presenter: Maximilian Mair
Session: Proffered Paper - CNS tumours
Resources:
Abstract
Slides
Webcast
363O - Clinical characterization of a real-life cohort of 6001 patients with brain metastases from solid cancers treated between 1986-2020
Presenter: Ariane Steindl
Session: Proffered Paper - CNS tumours
Resources:
Abstract
Slides
Webcast
364O - Intracranial efficacy of entrectinib in patients with NTRK fusion-positive solid tumours and baseline CNS metastases
Presenter: Thomas John
Session: Proffered Paper - CNS tumours
Resources:
Abstract
Slides
Webcast
Invited Discussant 360O and 361O
Presenter: Simone Niclou
Session: Proffered Paper - CNS tumours
Resources:
Slides
Webcast
Q&A and live discussion
Presenter: Emilie Le Rhun
Session: Proffered Paper - CNS tumours
Resources:
Webcast
Invited Discussant 362O, 363O and 364O
Presenter: Emilie Le Rhun
Session: Proffered Paper - CNS tumours
Resources:
Slides
Webcast